tolvaptan has been researched along with Heart Failure, Diastolic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nitta, K; Ogawa, T | 1 |
1 review(s) available for tolvaptan and Heart Failure, Diastolic
| Article | Year |
|---|---|
Clinical Impact of Left Ventricular Diastolic Dysfunction in Chronic Kidney Disease.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antidiuretic Hormone Receptor Antagonists; Antihypertensive Agents; Calcimimetic Agents; Calcium Channel Blockers; Diet, Sodium-Restricted; Diuretics; Echocardiography; Echocardiography, Doppler; Fibrosis; Heart Failure, Diastolic; Histamine Antagonists; Humans; Hypertrophy, Left Ventricular; Myocardium; Renal Dialysis; Renal Insufficiency, Chronic; Sodium-Glucose Transporter 2 Inhibitors; Tolvaptan; Ventricular Dysfunction, Left | 2018 |